⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

August 30, 2020Expert Opinion on Biological TherapyOpen Access

Brief overview of antibody–drug conjugate therapy for acute leukemia

Roland B. Walter

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Conventional multi-agent chemotherapy and allogeneic hematopoietic cell transplantation (HCT) are established cornerstones of curative-intent therapy for acute myeloid leukemia (AML) and acute lymp...

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Roland B. Walter (2020) studied this question.

synapsesocial.com/papers/6ac5ac4e839eb03f5c3e26fb https://doi.org/10.1080/14712598.2020.1817373

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome–Negative Precursor B-Lineage Acute Lymphoblastic LeukemiaPrognostic Study · 2010 · 421 citations
2Rituximab in B-Lineage Adult Acute Lymphoblastic LeukemiaCohort Study · 2016 · 353 citations
3Rituximab in the management of acute lymphoblastic leukemiaHuman Clinical Trial · 2018 · 21 citations
4Phase III Randomized Multicenter Study of a Humanized Anti-CD33 Monoclonal Antibody, Lintuzumab, in Combination With Chemotherapy, Versus Chemotherapy Alone in Patients With Refractory or First-Relapsed Acute Myeloid LeukemiaLate-Phase Clinical Trial · 2005 · 248 citations
5Randomized, phase IIb study of low-dose cytarabine and lintuzumab versus low-dose cytarabine and placebo in older adults with untreated acute myeloid leukemiaRCT · 2012 · 91 citations
6Addition of bevacizumab to chemotherapy in acute myeloid leukemia at older age: a randomized phase 2 trial of the Dutch-Belgian Cooperative Trial Group for Hemato-Oncology (HOVON) and the Swiss Group for Clinical Cancer Research (SAKK)RCT · 2012 · 76 citations
7Antibody-based therapy of acute myeloid leukemia with gemtuzumab ozogamicinOriginal Research · 2013 · 64 citations
8Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemiaOriginal Research · 2019 · 88 citations
9Three decades of PRPs: keeping the flame alive for blood as a source of repair and regenerationExpert Opinion on Biological Therapy · 2026
10The double-edged sword: a contemporary perspective on biologics for anti-cytokine syndromesExpert Opinion on Biological Therapy · 2026

More from Expert Opinion on Biological Therapy

More from University of Washington

More from Fred Hutch Cancer Center